3P BIOPHARMACEUTICALS - Trademark Details
Status: 807 - SU - Non-Final Action - Mailed
Serial Number
88303631
Word Mark
3P BIOPHARMACEUTICALS
Status
807 - SU - Non-Final Action - Mailed
Status Date
2021-11-08
Filing Date
2019-02-15
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
261709 - Curved line(s), band(s) or bar(s).
Published for Opposition Date
2021-02-02
Attorney Name
Law Office Assigned Location Code
L30
Employee Name
IN, SUNG HYUN
Statements
Indication of Colors claimed
The color(s) fuchsia and pink is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOPHARMACEUTICALS"
Description of Mark
The mark consists of the wording "3P" with "3" in pink and the "P" in fuchsia. To the left is a fuchsia curved line design forming a "3" superimposed over the letter "P", with the word "BIOPHARMACEUTICALS" in fuchsia in vertical form to the left of the design.
Goods and Services
Biopharmaceutical preparations for medical purposes, namely, monoclonal antibodies for use in vaccines, therapy, diagnosis and research, biotechnological origin antibodies for use in therapy, diagnosis and research, antibody fragments for use in therapy, diagnosis and research, fused antibody fragments for use in therapy, diagnosis and research, conjugated antibodies for use in therapy, diagnosis and research, engineered antibodies for use in therapy, diagnosis and research, vaccines and natural biomaterials for augmentation of bone and tissue, biotechnological scaffolds for cell therapy products and controlled released drugs, synthetic protein scaffolds, engineered antibodies scaffolds, non-antibody binding proteins for pharmaceutical and industrial applications, proteins for pharmaceuticals and industrial applications
Goods and Services
scientific and technical services in the field of pharmaceutical and biopharmaceutical preparations and medicines, namely, monoclonal antibodies for use in vaccines, therapy, diagnosis and research, biotechnological origin antibodies for use in therapy, diagnosis and research, antibody fragments for use in therapy, diagnosis and research, fused antibody fragments for use in therapy, diagnosis and research, conjugated antibodies for use in therapy, diagnosis and research, engineered antibodies for use in therapy, diagnosis and research, vaccines and natural biomaterials for augmentation of bone and tissue, biotechnological scaffolds for cell therapy products and controlled released drugs, synthetic protein scaffolds, engineered antibodies scaffolds, non-antibody binding proteins for pharmaceutical and industrial applications, proteins for pharmaceuticals and industrial applications; sanitary preparations for medical use; food for babies; nutritional supplements for humans and animals; medical plasters; medical dressings; teeth fillings and dental impression materials; all-purpose disinfectants; preparations for destroying vermin; fungicides, herbicides
Pseudo Mark
THREE P BIO PHARMACEUTICALS
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2019-03-08
Primary Code
005
First Use Anywhere Date
2006-12-31
First Use In Commerce Date
2019-02-28
Current Trademark Owners
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (sociedad de responsabilidad limitada (sl)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (sociedad de responsabilidad limitada (sl)).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (sociedad de responsabilidad limitada (sl)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Elizabeth Lee
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 2019-02-19 | NEW APPLICATION ENTERED IN TRAM |
| 2019-03-08 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| 2019-03-21 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| 2019-04-27 | ASSIGNED TO EXAMINER |
| 2019-05-08 | NON-FINAL ACTION WRITTEN |
| 2019-05-08 | NON-FINAL ACTION E-MAILED |
| 2019-05-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2019-11-07 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2019-11-07 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2019-11-07 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2019-12-04 | NON-FINAL ACTION WRITTEN |
| 2019-12-04 | NON-FINAL ACTION E-MAILED |
| 2019-12-04 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| 2020-06-04 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 2020-06-11 | ASSIGNED TO LIE |
| 2020-06-13 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 2020-06-13 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 2020-07-09 | FINAL REFUSAL WRITTEN |
| 2020-07-09 | FINAL REFUSAL E-MAILED |
| 2020-07-09 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| 2020-12-29 | EXAMINERS AMENDMENT -WRITTEN |
| 2020-12-29 | EXAMINERS AMENDMENT E-MAILED |
| 2020-12-29 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 2020-12-29 | EXAMINER'S AMENDMENT ENTERED |
| 2020-12-29 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 2021-01-13 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 2021-02-02 | PUBLISHED FOR OPPOSITION |
| 2021-02-02 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 2021-03-30 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 2021-09-28 | TEAS STATEMENT OF USE RECEIVED |
| 2021-10-12 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 2021-09-28 | USE AMENDMENT FILED |
| 2021-10-12 | STATEMENT OF USE PROCESSING COMPLETE |
| 2021-11-08 | SU - NON-FINAL ACTION - WRITTEN |
| 2021-11-08 | NON-FINAL ACTION E-MAILED |
| 2021-11-08 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
